CRS & HIPEC
Cytoreductive Surgery + Heated Intraperitoneal Chemotherapy
A revolutionary treatment combining surgical removal of visible tumors with heated chemotherapy for peritoneal carcinomatosis.
Dr. Dharanikota has extensive experience in CRS-HIPEC procedures, having completed advanced training and performed over 100 cases with excellent outcomes.
CRS-HIPEC Procedure Steps
A comprehensive two-phase treatment approach combining surgery with heated chemotherapy
Treatment Indications
CRS-HIPEC is indicated for specific types of peritoneal surface malignancies
Peritoneal Carcinomatosis
Colorectal Cancer
Advanced colorectal cancer with peritoneal spread, offering hope for improved survival outcomes.
Ovarian Cancer
Primary or Recurrent
Advanced ovarian cancer with peritoneal involvement, particularly in recurrent disease settings.
Appendiceal Cancer
Pseudomyxoma Peritonei
Rare appendiceal cancers causing mucin accumulation in the peritoneal cavity.
Gastric Cancer
Peritoneal Metastases
Advanced gastric cancer with peritoneal dissemination in selected patients.
Advantages of CRS-HIPEC
Unique benefits of combining surgical cytoreduction with heated chemotherapy
Treatment Outcomes
Evidence-based results demonstrating the effectiveness of CRS-HIPEC
Complete Cytoreduction Rate
Achieving optimal tumor removal
5-Year Survival
Significant improvement vs. systemic therapy alone
Morbidity Rate
Low complication rate in experienced centers
Quality of Life
Better symptom control and function
CRS-HIPEC Expertise
Dr. Dharanikota's specialized training and experience in CRS-HIPEC procedures ensures optimal patient outcomes.
Advanced Treatment for Complex Cases
Discover if CRS-HIPEC is the right treatment option for your condition. Schedule a consultation to discuss your case.